See more : Softline Holding PLC (SFTL.ME) Income Statement Analysis – Financial Results
Complete financial analysis of PharmAust Limited (PAA.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PharmAust Limited, a leading company in the Biotechnology industry within the Healthcare sector.
- Siam City Cement Public Company Limited (SCCC-R.BK) Income Statement Analysis – Financial Results
- UBC MEDICAL INDONESIA TBK (LABS.JK) Income Statement Analysis – Financial Results
- CoStar Group, Inc. (CSGP) Income Statement Analysis – Financial Results
- MonotaRO Co., Ltd. (3064.T) Income Statement Analysis – Financial Results
- Garware Synthetics Limited (GARWSYN.BO) Income Statement Analysis – Financial Results
PharmAust Limited (PAA.AX)
About PharmAust Limited
PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers, and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of cancer. The company also provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries worldwide. The company has a research agreement with the Walter and Eliza Hall Institute to investigate the effects of MPL upon human T-lymphotrophic virus-1 (HTLV-1) infections in vitro. It serves drug discovery and pharmaceutical industries. PharmAust Limited was incorporated in 2000 and is based in Bentley, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 2.82M | 3.38M | 2.14M | 3.20M | 4.35M | 3.26M | 3.31M | 2.72M | 2.37M | 1.94M | 1.71M | 1.62M | 1.55M | 1.64M | 1.76M | 2.79M | 7.13M | 6.11M | 3.21M | 306.46K | 67.97K | 678.00K | 0.00 |
| Cost of Revenue | 1.64K | 3.75M | 3.60M | 2.91M | 3.62M | 333.63K | 289.32K | 340.62K | 234.38K | 207.78K | 222.67K | 220.69K | 176.64K | 142.31K | 209.46K | 193.72K | 711.18K | 3.02M | 1.84M | 1.32M | 138.97K | 35.20K | 148.45K | 0.00 |
| Gross Profit | -1.64K | -929.54K | -223.52K | -771.53K | -424.02K | 4.01M | 2.97M | 2.97M | 2.48M | 2.16M | 1.72M | 1.49M | 1.44M | 1.41M | 1.43M | 1.56M | 2.08M | 4.11M | 4.26M | 1.89M | 167.49K | 32.77K | 529.55K | 0.00 |
| Gross Profit Ratio | 0.00% | -32.92% | -6.61% | -36.05% | -13.27% | 92.32% | 91.12% | 89.70% | 91.38% | 91.24% | 88.52% | 87.10% | 89.08% | 90.83% | 87.23% | 88.97% | 74.55% | 57.68% | 69.85% | 58.96% | 54.65% | 48.22% | 78.11% | 0.00% |
| Research & Development | 3.85M | 1.03M | 758.66K | 554.14K | 605.35K | 1.04M | 463.88K | 329.30K | 702.04K | 629.15K | 211.64K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 53.25K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 1.66M | 1.77M | 1.46M | 1.14M | 1.41M | 1.36M | 1.30M | 1.75M | 1.25M | 1.11M | 2.05M | 2.24M | 2.18M | 2.00M | 1.91M | 2.08M | 4.90M | 4.55M | 3.63M | 1.06M | 1.43M | 1.63M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.91M | 3.56M | 2.52M | 1.78M | 2.18M | 1.72M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 783.02K | 0.00 |
| SG&A | 2.81M | 1.66M | 1.77M | 1.46M | 1.14M | 4.32M | 4.92M | 3.82M | 3.52M | 3.43M | 2.83M | 2.05M | 2.24M | 2.18M | 2.00M | 1.91M | 2.08M | 4.90M | 4.55M | 3.63M | 1.06M | 1.43M | 2.41M | 0.00 |
| Other Expenses | 0.00 | 995.37K | 1.13M | 1.52M | 924.23K | 676.30K | 387.66K | 453.40K | 700.03K | 502.12K | 58.60K | 53.06K | 3.43M | 9.64K | 122.28K | 1.82M | -803.26K | 3.00K | 742.54K | 22.44K | 43.67K | 89.18K | -3.72M | -2.38M |
| Operating Expenses | 6.66M | 2.69M | 2.53M | 2.02M | 1.75M | 5.53M | 5.50M | 4.28M | 6.41M | 4.13M | 3.10M | 2.11M | 5.67M | 2.25M | 2.07M | 2.18M | 4.65M | 10.47M | 7.58M | 3.86M | 1.34M | 2.10M | 578.00K | 250.67K |
| Cost & Expenses | 6.66M | 6.45M | 6.13M | 4.93M | 5.37M | 5.87M | 5.79M | 4.62M | 6.64M | 4.34M | 3.32M | 2.33M | 5.85M | 7.39M | 2.27M | 2.38M | 5.36M | 10.89M | 9.42M | 5.05M | 1.34M | 2.29M | 4.40M | 250.67K |
| Interest Income | 24.47K | 81.03K | 536.00 | 14.72K | 3.29K | 30.02K | 8.55K | 33.45K | 3.10K | 45.14K | 65.03K | 10.63K | 7.72K | 33.98K | 178.23K | 159.77K | 64.31K | 59.00K | 47.81K | 49.47K | 31.04K | 21.30K | 93.29K | 185.50K |
| Interest Expense | 0.00 | 81.86K | 88.51K | 78.99K | 118.50K | 47.82K | 28.35K | 59.38K | 39.93K | 3.56K | 2.67K | 33.59K | 40.59K | 4.37K | 105.33K | 143.35K | 129.30K | 280.00K | 77.25K | 28.63K | 46.57K | 120.28K | 82.00K | 266.00 |
| Depreciation & Amortization | 1.64K | 326.55K | 314.93K | 298.26K | 274.64K | 172.43K | 118.61K | 123.09K | 109.23K | 77.15K | 53.37K | 48.71K | 57.85K | 65.18K | 62.18K | 58.73K | 296.29K | 810.00K | 419.24K | 99.13K | 207.73K | 670.00K | 578.00K | 250.67K |
| EBITDA | -9.45M | -3.30M | -1.30M | -960.06K | -968.86K | -1.33M | -2.37M | -1.16M | -3.78M | -1.84M | -1.26M | -556.87K | -4.16M | -5.73M | -271.08K | 22.49K | -3.78M | -5.49M | -2.26M | -3.12M | -1.02M | -1.28M | -3.05M | -1.84M |
| EBITDA Ratio | 0.00% | -116.72% | -71.99% | -116.40% | -59.34% | -31.03% | -74.00% | -35.89% | -64.14% | -79.83% | -68.55% | -32.56% | -257.26% | -47.01% | -16.52% | 1.28% | -163.37% | -76.92% | -34.49% | -59.94% | -332.98% | -1,887.36% | -449.12% | 0.00% |
| Operating Income | -6.66M | -3.62M | -2.75M | -2.79M | -2.17M | -1.52M | -2.53M | -1.31M | -1.85M | -1.97M | -1.38M | -616.21K | -4.23M | -5.84M | -633.77K | -622.30K | -2.57M | -6.30M | -3.32M | -1.82M | -992.88K | -1.97M | -3.72M | -250.67K |
| Operating Income Ratio | 0.00% | -128.28% | -81.30% | -130.34% | -67.93% | -35.00% | -77.64% | -39.61% | -68.16% | -83.09% | -71.31% | -36.03% | -261.31% | -375.99% | -38.62% | -35.45% | -91.79% | -88.38% | -54.30% | -56.59% | -323.98% | -2,904.41% | -549.34% | 0.00% |
| Total Other Income/Expenses | -2.79M | -2.96M | 1.04M | -64.27K | 809.02K | -30.02K | 8.55K | -33.45K | -1.37M | 45.14K | 65.03K | -22.96K | -32.87K | 39.25K | 195.17K | 442.70K | -3.20M | 2.70M | 563.10K | -1.55M | -1.59M | -98.98K | 18.65K | -266.00 |
| Income Before Tax | -9.45M | -6.21M | -1.71M | -1.34M | -1.36M | -1.55M | -2.52M | -1.34M | -3.93M | -1.93M | -1.32M | -639.17K | -4.26M | -5.80M | -438.60K | -179.60K | -5.77M | -6.58M | -2.75M | -3.36M | -2.58M | -2.07M | -3.71M | -2.09M |
| Income Before Tax Ratio | 0.00% | -219.96% | -50.52% | -62.48% | -42.62% | -35.69% | -77.38% | -40.62% | -144.50% | -81.18% | -67.95% | -37.37% | -263.34% | -373.46% | -26.73% | -10.23% | -206.40% | -92.20% | -45.08% | -104.76% | -843.41% | -3,050.03% | -546.46% | 0.00% |
| Income Tax Expense | -553.44K | 1.00 | 3.00 | -3.00 | 3.00 | 570.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -113.65K | 7.72K | 14.01K | 227.61K | 569.65K | -2.23M | 283.00K | 819.80K | -3.36M | -2.58M | -2.07M | -3.71M | -2.09M |
| Net Income | -9.03M | -6.21M | -1.71M | -1.34M | -1.36M | -1.55M | -2.52M | -1.34M | -3.93M | -1.93M | -1.32M | -514.88K | -4.26M | -5.80M | -438.60K | -179.60K | -5.77M | -6.58M | -2.75M | -3.36M | 36.86K | -2.07M | -3.71M | -2.09M |
| Net Income Ratio | 0.00% | -219.96% | -50.52% | -62.48% | -42.62% | -35.69% | -77.38% | -40.62% | -144.50% | -81.18% | -67.95% | -30.11% | -263.34% | -373.46% | -26.73% | -10.23% | -206.40% | -92.20% | -45.08% | -104.76% | 12.03% | -3,050.03% | -546.46% | 0.00% |
| EPS | -0.02 | -0.02 | -0.01 | 0.00 | 0.00 | -0.01 | -0.02 | -0.01 | -0.04 | -0.03 | -0.02 | -0.02 | -0.16 | -0.36 | -0.03 | -0.01 | -0.48 | -1.05 | -0.61 | -1.00 | -1.35 | -1.58 | -3.44 | -2.58 |
| EPS Diluted | -0.02 | -0.02 | -0.01 | 0.00 | 0.00 | -0.01 | -0.02 | -0.01 | -0.04 | -0.03 | -0.02 | -0.02 | -0.16 | -0.36 | -0.03 | -0.01 | -0.48 | -1.05 | -0.61 | -1.00 | -1.35 | -1.58 | -3.44 | -2.58 |
| Weighted Avg Shares Out | 370.81M | 321.01M | 316.88M | 315.74M | 296.03M | 219.33M | 146.58M | 124.57M | 92.50M | 75.85M | 66.61M | 31.04M | 26.15M | 16.19M | 14.58M | 13.86M | 12.03M | 6.26M | 4.54M | 3.36M | 1.89M | 1.31M | 1.08M | 813.21K |
| Weighted Avg Shares Out (Dil) | 370.81M | 321.01M | 316.88M | 315.74M | 296.03M | 219.33M | 146.58M | 124.57M | 92.50M | 75.85M | 66.61M | 31.04M | 26.15M | 16.19M | 14.58M | 13.86M | 12.03M | 6.26M | 4.54M | 3.36M | 1.89M | 1.31M | 1.08M | 813.21K |
Source: https://incomestatements.info
Category: Stock Reports